Sanibel Captiva Trust Company’s ADC Therapeutics ADCT Stock Holding History

Sanibel Captiva Trust Company’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Buy	230,435 +80,000	+53%	+$233K	0.01%	424
2026 Q1	$564K	Buy	150,435 +37,435	+33%	+$148K	0.02%	294
2025 Q4	$399K	Hold	113,000	–	–	0.01%	323
2025 Q3	$452K	Hold	113,000	–	–	0.01%	307
2025 Q2	$303K	Hold	113,000	–	–	0.01%	347
2025 Q1	$159K	Hold	113,000	–	–	0.01%	382
2024 Q4	$225K	Hold	113,000	–	–	0.01%	363
2024 Q3	$356K	Hold	113,000	–	–	0.01%	312
2024 Q2	$357K	Buy	113,000 +10,000	+10%	+$39.7K	0.01%	297
2024 Q1	$462K	Buy	+103,000	New	+$380K	0.02%	265

Other funds holding ADCT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sanibel Captiva Trust Company's ADCT Position: Q2 2026 in Review

Sanibel Captiva Trust Company increased its ADC Therapeutics (ADCT) stake by 53% in Q2 2026, buying an estimated $233K and bringing the position to 230,435 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #424.

Sanibel Captiva Trust Company first reported a position in ADCT in Q1 2024 and has held it in 10 quarters since. The position peaked at $564K in Q1 2026. 114 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

Sanibel Captiva Trust Company held 230,435 shares of ADC Therapeutics worth $247K as of Q2 2026.
Sanibel Captiva Trust Company bought 80,000 ADC Therapeutics shares in Q2 2026, an estimated $233K.
ADC Therapeutics made up 0.01% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #424 holding.
Sanibel Captiva Trust Company first reported a position in ADC Therapeutics in Q1 2024 and has held it in 10 quarters since.
Sanibel Captiva Trust Company's ADC Therapeutics position peaked at $564K in Q1 2026.
114 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.